Collectively, these findings provide important insights into the molecular mechanisms underlying CHI3L1-mediated RA progression and indicate that TIMP1 and AQP9 may serve as potential biomarkers for RA. The gene discussed is AQP9; the disease is rheumatoid arthritis.